Hosted on MSN1mon
Leerink Partners Downgrades 10x Genomics (TXG)Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Outperform ... financial advisors, and small hedge funds.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback